Daqing Xia

Risk-adapted Treatment Strategy For COVID-19 Patients

Changcheng Zheng, Jinquan Wang, Hui Guo et al. · International Journal of Infectious Diseases · 2020 · 94 citations · Full text

Pharmacy, Infectious Diseases, Risk Management +12

Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial

Dongsheng Wang, Binqing Fu, Zhen Peng et al. · Frontiers of Medicine · 2021 · 80 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +16

Neutrophil-to-Lymphocyte Ratios Are Closely Associated With the Severity and Course of Non-mild COVID-19

Sen Qun, Yulan Wang, Jun Chen et al. · Frontiers in Immunology · 2020 · 46 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

The efficacy of furazolidone and metronidazole in the treatment of chronic gastritis associated with Helicobacter (Campylobacter) pylori--a randomized double-blind placebo-controlled clinical trial.

S D Xiao, W Z Liu, Daqing Xia et al. · PubMed · 1990 · 29 citations

Medicine, Pharmacology, Pharmacotherapy +16

Tocilizumab Ameliorates the Hypoxia in COVID-19 Moderate Patients with Bilateral Pulmonary Lesions: A Randomized, Controlled, Open-Label, Multicenter Trial

Dongsheng Wang, Binqing Fu, Zhen Peng et al. · SSRN Electronic Journal · 2020 · 18 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +11